Legislation that increases transparency and consumer choice in the prescription drug marketplace is now law. HB 943 (Act 67) ends the long-standing “gag clause” imposed on pharmacists, barring them from informing customers of lower-cost alternatives at the pharmacy counter. Such a prohibition stems from language contained in some pharmacy contracts that disallows pharmacists from disclosing any information to their customers that could potentially reduce their out-of-pocket costs for medications. The bill was signed into law July 23 and becomes effective in 60 days.
